Events
Register and find information for upcoming events from BioSpace and partners.
Interested in publishing your upcoming event on BioSpace? Submit events here.
Interested in putting on your own event? Talk to us.
Upcoming Events
Disease is driven by complex biological networks that remain only partially understood until experimentally resolved as a whole. Targets and compounds advance without clear biological understanding, leading to failure. AI and large-scale experimental data have scaled hypotheses and insights. The bottleneck now shifts to biological resolution.
Wednesday, May 13, 2026 11am–12pm EDT
·
Virtual
Join researchers and industry partners—from major pharmaceutical companies and small-mid-size biotech companies—to share early oncology pipelines and innovation strategies for drug development and presents analysts and investors with new partnership and licensing opportunities to advance these concepts.
April 16, 2026 - April 17, 2026
·
San Diego, CA
Navigating AI, Globalization, and Integration while Demonstrating Strategic Value
Monday, April 20, 2026 7:30–11:30am EDT
·
Barcelona, Spain
In this webinar, an AsymBio expert will discuss robust analytical strategies for tackling challenges in analytical method development for CQA measurement, including DAR determination, drug load distribution, free drug, and charge variant analysis.
Wednesday, April 22, 2026 10–11am EDT
·
Virtual
Work with the BioSpace Insights team to engage decision-makers through thoughtful and impactful content.
Past Events
Watch this critical discussion on how regulators and biotech companies can bridge the expectation gap during the regulatory review process to ensure novel therapies reach patients in a timely manner—because patients don’t have time to wait.
More Past Events
This webinar provides a clear-eyed assessment of current hiring conditions across biopharma, exploring which roles and skills are in demand, where opportunities are emerging, and how hiring practices are evolving.
The FDA is undergoing a major transformation in its drug approval processes, regulatory oversight and transparency initiatives. This webinar explores the implications of these reforms and what they mean for innovation, compliance and strategy in the biopharma industry.
This discussion focuses on how sequencing-based insights can power AI-driven design and data-driven validation, helping to develop safe and effective drugs for treating and preventing disease.
During this webinar BioSpace sits down with former FDA Chief Information Officer Vid Desai to discuss the potential advantages and pitfalls of deregulation stemming from one of President Donald Trump’s first executive orders. Together, they uncover what this shift means for drugmakers, compliance and patient safety.
This webinar, tailored for scientists in academia, biotech, and pharma, explores how intelligent mRNA designs can reduce experimental workloads and improve mRNA performance and efficacy.